Symposium ALLOD: “Allosteric Drug Design: where Academia meets Pharma”

The IFM team is pleased to inform that the 3^rd on-site meeting of the ALLODD consortium funded by the European Union’s Horizon 2020 Research and Innovation Programme will be held at the University Strasbourg on May 22-26. The event will include a 2-day symposium entitled “Allosteric Drug Design: where Academia meets Pharma” where top academic players and big pharma companies nearby Strasbourg such as Novartis, Roche, and Merck will meet, discuss, and find links.

The symposium will take place at the Salle des Conferences at ISIS and start on Monday, May 22 at 2:00 pm. Attendance is free of charge, but a formal registration is needed.

If you plan to attend, please, follow the link below and complete the registration form:

https://www.allodd-itn.eu/allostery-in-drug-discovery-awareness-event-and-symposium.html

 

Short description:

The event will start with a 2-day symposium entitled “Allosteric Drug Design: where Academia meets Pharma”, whose goal is to provide a forum where academics and industrial partners working on allosteric drug design could meet, discuss, and find links. Big Pharma companies nearby the Strasbourg area such as Novartis, Roche, and Merck will be part of the program. Day 3 is dedicated to progress reports by ESRs and discussions with supervisors. Hands-on tutorials for ESRs on Machine Learning and Molecular Dynamics will be presented on Day 4 by professors from the University of Strasbourg. Day 5 includes soft-skills workshops on communicating research results and grant writing provided by our partner Sci-Co.

 

The programme of the meeting is available at:

https://www.allodd-itn.eu/uploads/9/4/6/0/9460131/program_08may23.pdf

 

We hope to see you there

Marco Cecchini and the organization team

Contact :

Marco Cecchini, équipe IFM, Institut de Chimie de Strasbourg (UMR 7177).


 

 

ALLODD (Allosteric Drug Discovery): https://www.allodd-itn.eu/

 

Speakers:

Download here the flyer of the event

 

Sponsors :